NCT02428764 2024-12-10
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
Phase 2 Withdrawn
Sun Yat-sen University
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Spectrum Pharmaceuticals, Inc